Sky Solar’s Chairman and CEO Su Weili Delivers Impressive Speech

The most talked point of the recently concluded Second Sino-EU International Solar PV Industry Development Forum is an exhaustive speech delivered by Mr. Su Weili, who leads Sky Solar Holdings Co., Ltd, as its Chairman and CEO. Being a part of Chinese solar PV industry from 2001 Mr. Su is completely engaged in turnkey solar power projects that produce productive results.

During the meet Su recalled the fast growth in global PV industry during the last five years and significant contribution from China in the solar PV industrial development. He quoted the rapid growth of industry and narrated the incredible pressure faced by the manufacturing companies in pushing the products. He explained how the PV markets all over Europe and Germany have reached the maturity stage and are currently facing the problem of saturation. He sounded very optimistic about countries such as France, Czech Republic, Canada and USA growing as solar hubs for the countries nearby. He reiterated the need to adjust the production techniques and development plans intone with changes in the market. Su, gladly shared the growth model of Sky Solar in the areas such as project development, supply chain maintenance, quality management, technological development and support and financial support. He concluded the speech saying that Sky Solar is fully committed to the growth of low carbon economy while bettering the living quality of fellow humans.

The forum witnessed participation by over 200 top notch solar experts and managers from USA, Asia and Europe. The attendees at the convention participated and aired their views on important topics such as effective promoting of the PV industry and its development, venturing improvements in the current applications, inviting global investment and most importantly cooperation between the industry segments.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.